Gail P Goldstein
Biographic Data
| ID | 6079104 |
|---|---|
| NAME | Gail P Goldstein |
| GIVEN NAMES | Gail P |
| FAMILY NAME | Goldstein |
| SIGNATURE | GOLDSTEIN G P |
| AFFILIATIONS | At the time this article was written, Kate Rube, Maggie Veatch, Rachel Sacks, Megan Lent, Gail P. Goldstein, and Karen K. Lee were with the Bureau of Chronic Disease Prevention and Tobacco Control, New York City Department of Health and Mental Hygiene, Queens, NY. Katy Huang is with the Division of Health Care Access and Improvement, New York City Department of Health and Mental Hygiene. |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 2 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 1 |
Implementing a Methadone Delivery System in New York City in Response to Covid-19
Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation of fentanyl, ensuring continuity of methadone treatment during the COVID-19 pandemic is a vital public health priority. (Am J Public Health. 2021;111…
How the Nurses’ Health Study Helped Americans Take the Trans Fat Out
In 2007, New York City (NYC) became the first US municipality to restrict trans fat use through a regulatory process in all foodservice establishments. After years of local policy change and accumulating evidence, in 2015, the US Food and Drug Administration (FDA) finalized its determination to remove the “generally recognized as safe” (GRAS) status for partially hydrogenated oils, the main dietary source of trans fat.1 This action would remove v…
Developing Built Environment Programs in Local Health Departments: Lessons Learned From a Nationwide Mentoring Program
Local health departments (LHDs) have a key role to play in developing built environment policies and programs to encourage physical activity and combat obesity and related chronic diseases. However, information to guide LHDs’ effective engagement in this arena is lacking. During 2011–2012, the New York City Department of Health and Mental Hygiene (DOHMH) facilitated a built environment peer mentoring program for 14 LHDs nationwide. Program object…
Developing Built Environment Programs in Local Health Departments: Lessons Learned From a Nationwide Mentoring Program
Local health departments (LHDs) have a key role to play in developing built environment policies and programs to encourage physical activity and combat obesity and related chronic diseases. However, information to guide LHDs’ effective engagement in this arena is lacking. During 2011–2012, the New York City Department of Health and Mental Hygiene (DOHMH) facilitated a built environment peer mentoring program for 14 LHDs nationwide. Program object…
Developing Built Environment Programs in Local Health Departments: Lessons Learned From a Nationwide Mentoring Program
Local health departments (LHDs) have a key role to play in developing built environment policies and programs to encourage physical activity and combat obesity and related chronic diseases. However, information to guide LHDs’ effective engagement in this arena is lacking. During 2011–2012, the New York City Department of Health and Mental Hygiene (DOHMH) facilitated a built environment peer mentoring program for 14 LHDs nationwide. Program object…
How the Nurses’ Health Study Helped Americans Take the Trans Fat Out
In 2007, New York City (NYC) became the first US municipality to restrict trans fat use through a regulatory process in all foodservice establishments. After years of local policy change and accumulating evidence, in 2015, the US Food and Drug Administration (FDA) finalized its determination to remove the “generally recognized as safe” (GRAS) status for partially hydrogenated oils, the main dietary source of trans fat.1 This action would remove v…
Implementing a Methadone Delivery System in New York City in Response to Covid-19
Opioid agonist medication, including methadone, is considered the first-line treatment for opioid use disorder. Methadone, when taken daily, reduces the risk of fatal overdose; however, overdose risk increases following medication cessation. Amid an overdose epidemic accelerated by the proliferation of fentanyl, ensuring continuity of methadone treatment during the COVID-19 pandemic is a vital public health priority. (Am J Public Health. 2021;111…
Medicine (3 works) · Environmental health (2 works) · (+)-Naloxone (1 works) · 2019-20 coronavirus outbreak (1 works) · Administration (probate law) (1 works) · Agricultural economics (1 works) · Anesthesia (1 works) · Buprenorphine (1 works) · Business (1 works) · Consumer Attitudes and Food Labeling (1 works)